CleanPlex Limb-Girdle Muscular Dystrophy NGS Panel • NUCLEUS BIOTECH
NUCLEUS BIOTECH • CleanPlex Limb-Girdle Muscular Dystrophy NGS Panel
The CleanPlex® Limb-Girdle Muscular Dystrophy NGS Panel for Illumina® or Ion Torrent™ is a pre-designed and made-to-order multiplex PCR / amplicon-based targeted sequencing (NGS) assay designed to examine the germline variants or mutations across 38 genes associated with Limb-Girdle Muscular Dystrophy. The panel targets all the exonic regions of those genes and the flanking intronic sequences. Compatible with just 10 ng of DNA, sequencing-ready libraries can be prepared using a streamlined workflow in just 3 hours. The pre-designed panel is optimized in silico to deliver data with high on-target performance and high coverage uniformity to ensure efficient use of sequencing reads.
This product is made to order. Once we receive your order, we will synthesize the panel and the kit will contain CleanPlex Multiplex PCR Primers and CleanPlex Targeted Library Kit. CleanPlex Indexed PCR Primers and CleanMag® Magnetic Beads can be ordered separately to complete the workflow from input DNA to sequencing-ready NGS libraries.
You have the option to modify the existing content of this pre-designed panel. Please contact us for a quote.
Genetic characterization of Limb Girdle Muscular Dystrophies and Pompe Disease in a large Argentine cohort - ScienceDirect
Clinical, pathological, imaging, and genetic characterization in a Taiwanese cohort with limb-girdle muscular dystrophy, Orphanet Journal of Rare Diseases
Limb-girdle muscular dystrophies — international collaborations for translational research
SciELO - Brasil - Limb-girdle muscular dystrophy: an immunohistochemical diagnostic approach Limb-girdle muscular dystrophy: an immunohistochemical diagnostic approach
Limb Girdle Muscular Dystrophy Variant Curation Expert Panel - ClinGen
Frontiers Emerging gene editing strategies for Duchenne muscular dystrophy targeting stem cells
The genetic and molecular basis of muscular dystrophy: roles of cell–matrix linkage in the pathogenesis
Rachel Reynolds - Research Associate II - Asklepios BioPharmaceutical, Inc. (AskBio)
Muscular Dystrophies
3D Artificial Skeletal Muscle Constructs Derived from Healthy and
Atamyo Therapeutics Submits CTA in Europe for Limb-Girdle Muscular Dystrophy Type 2C/R5 Gene Therapy
Curelgmd2i Foundation
Limb Girdle Muscular Dystrophy Variant Curation Expert Panel - ClinGen